Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iRhythm Holdings (IRTC) Change in Accured Expenses (2016 - 2023)

Historic Change in Accured Expenses for iRhythm Holdings (IRTC) over the last 9 years, with Q4 2023 value amounting to $8.4 million.

  • iRhythm Holdings' Change in Accured Expenses rose 3104.2% to $8.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $19.3 million, marking a year-over-year increase of 3333.79%. This contributed to the annual value of $19.3 million for FY2023, which is 3333.79% up from last year.
  • Latest data reveals that iRhythm Holdings reported Change in Accured Expenses of $8.4 million as of Q4 2023, which was up 3104.2% from $12.2 million recorded in Q3 2023.
  • In the past 5 years, iRhythm Holdings' Change in Accured Expenses registered a high of $13.3 million during Q3 2021, and its lowest value of -$11.2 million during Q1 2023.
  • Moreover, its 5-year median value for Change in Accured Expenses was $4.2 million (2020), whereas its average is $2.5 million.
  • Within the past 5 years, the most significant YoY rise in iRhythm Holdings' Change in Accured Expenses was 197162.16% (2021), while the steepest drop was 15083.17% (2021).
  • Quarter analysis of 5 years shows iRhythm Holdings' Change in Accured Expenses stood at $367000.0 in 2019, then skyrocketed by 1718.26% to $6.7 million in 2020, then plummeted by 150.83% to -$3.4 million in 2021, then soared by 288.71% to $6.4 million in 2022, then soared by 31.04% to $8.4 million in 2023.
  • Its Change in Accured Expenses stands at $8.4 million for Q4 2023, versus $12.2 million for Q3 2023 and $10.0 million for Q2 2023.